ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Research Associate I, Pharmaceutical Development at Nurix - ApplyBlast

Research Associate I, Pharmaceutical Development

Nurix

1 month ago

3.9 on Glassdoor

Brisbane, California, United States

Onsite

Contract

Junior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Nurix Therapeutics is seeking a Research Associate I to support drug discovery and product development for small molecules, ranging from early discovery to clinical trial enabling studies. The role involves preparing and characterizing preclinical formulations, conducting stability and solubility testing, and assisting with formulation development for oral solid dosage forms. This position requires strong laboratory skills and a thorough understanding of basic chemistry principles to contribute to internal and external presentations and publications.

Responsibilities

Prepare and characterize preclinical formulations for multiple programs
Perform stability and solubility testing using HPLC/UPLC
Assist with pre-formulation and formulation development for oral solid dosage forms

Skills

Qualifications

BS/BA in chemistry, pharmaceutics, engineering, or related field

About Nurix

nurixtx.com

Headquarters

Brisbane, California, United States

Company Size

201-500 employees

Founded

2012

View Profile

Nurix Therapeutics is a clinical-stage biopharmaceutical company developing medicines that harness targeted protein degradation to treat cancer and autoimmune diseases. Using a proprietary platform that combines small-molecule degraders and Degradation Activating Compounds (DACs) to engage E3 ubiquitin ligases and the ubiquitin–proteasome system, Nurix aims to selectively remove disease-causing proteins. The company advances multiple discovery and development programs and collaborates with partners to translate its platform into novel therapies. Their mission, "Medicines to Outmatch Disease," guides efforts to create differentiated, targeted treatments.